LUNG FY 2024 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

FY 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$84M+22.0% YoY

Gross Profit

$62M74.0% margin

Operating Income

-$58M-68.9% margin

Net Income

-$56M-67.3% margin

EPS (Diluted)

$-1.44

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$33M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$163M

Total Liabilities

$77M

Stockholders' Equity

$86M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$84M	$69M	+22.0%
Gross Profit	$62M	$51M	+22.2%
Operating Income	-$58M	-$62M	+6.8%
Net Income	-$56M	-$61M	+7.3%